91AV原创

Tag - obesity

 
 

OBESITY

While previous studies had shown that a continued high-calorie diet slows down brain functions, researchers had yet to unravel the complex mechanism on a molecular level.
JAPAN / Science & Health
Oct 15, 2026
High-calorie diet causes brain nerve abnormalities, researchers find
A team in Japan has found that a cognitive decline from continually eating high-calorie food is due to abnormalities in the synapses.
North Korean leader Kim Jong Un speaks in Pyongyang on Sept. 21.
ASIA PACIFIC
Sep 30, 2026
North Korean leader ‘extremely obese,’ Seoul spy agency says
Kim Jong Un’s health is closely watched, as his sudden death could raise questions over succession and stability in the nuclear-armed state.
Taiane Torres da Silva, 32, who works at a pet shop, prepares a tirzepatide injection at home in Nova Iguacu, Brazil, on Aug. 17.
BUSINESS
Sep 1, 2026
Booming weight-loss drug demand in Brazil fuels thriving black market and health fears
Between 2018 and mid-August 2026, Brazilian authorities recorded 83 deaths, which are under investigation, and over 3,600 complications linked to weight-loss drugs.
People walk past billboards from Innovent Biologics and Meituan displayed on a wall in a metro station in Shanghai on July 6.
BUSINESS / Companies
Aug 24, 2026
Snoring, subways and stealth ads: How big pharma targets China’s waistline
Local restrictions prevent drug companies from directly advertising prescription medicines in the world’s second-largest drug market.
Novo Nordisk is getting a boost from its new Wegovy  weight-loss pill.
BUSINESS
Aug 3, 2026
Obesity battle heats up again as Novo claws its way back into race with Lilly
Novo Nordisk is getting a boost from its new Wegovy weight-loss pill that ?is holding onto its lead against Eli Lilly’s more recently launched Foundayo.
A surgeon fills a syringe with Eli Lilly's Mounjaro, a tirzepatide injection drug used for treating type 2 diabetes and weight loss.
JAPAN / Science & Health / EXPLAINER
Jun 10, 2026
‘Thinness equals beauty’: Mounjaro misuse among women sparks health debate in Japan
The nation is one of the leanest in the world, making the misuse of the diabetes drug simply for weight loss that much more alarming.
Male participants line up to get weighed and have their waist measured at a local community center in Wuxi, in eastern China's Jiangsu province.
ASIA PACIFIC / Society
Apr 17, 2026
Chinese slimmers trade lost fat for beef
Rising obesity rates have led to unusual weight-loss programs springing up across China.
More and more people are using Mounjaro, a drug used to treat diabetes, in the hopes of losing weight.
JAPAN / Society / Regional Voices: Kyushu
Jan 12, 2026
Doctors warn of risks of taking diabetes drug to lose weight
There have been reports of people experiencing adverse side effects, according to the Pharmaceuticals and Medical Devices Agency.
Gray wolves and ancient dire wolves diverged millions of years ago, yet groundbreaking efforts to resurrect the extinct species by modifying modern wolves cannot replace the lost ecosystems that once sustained it.
COMMENTARY / World
Dec 30, 2025
Science still made incredible breakthroughs while under attack
Scientists around the world produced amazing discoveries every day — some of which made a big splash while others didn’t get nearly the attention they deserved.
A Novo Nordisk office in Bagsvaerd, on the outskirts of Copenhagen
BUSINESS / Companies
Oct 22, 2025
Novo’s board bust-up to sharpen drugmaker’s focus on U.S. consumers
The Danish drugmaker that initially soared on the success of its obesity drug has lost its market lead to U.S. rival Eli Lilly and cheaper copycats.
Recent research shows obesity may be driven by ultraprocessed and hyperpalatable foods that disrupt fullness signals and lead to overeating.
COMMENTARY / World
Oct 13, 2025
What if everything we think about obesity is wrong?
New research offers novel insight into the causes of overeating but it’s being lost to political posturing.
Chugai Pharmaceutical shares sank as much as 20% in Tokyo on Friday after a study revealed that an obesity drug it licensed to Eli Lilly & Co. resulted in lower weight loss and higher rates of nausea and vomiting than anticipated.
BUSINESS / Companies
Aug 8, 2025
Chugai stock drops the most since 1977 on disappointing obesity drug data
A study showed the drug, which it has licensed to Eli Lilly & Co., resulted in lower weight loss and higher rates of nausea and vomiting than anticipated.
Scientists say a recently published study could help explain why women are typically less prone to weight-related conditions. The research may lead to new therapies that target calorie-burning mechanisms.
JAPAN / Science & Health
Jul 15, 2025
Japanese scientists discover clue to why women burn more fat than men
Scientists say their findings could help explain why women are typically less prone to weight-related conditions and may lead to new therapies.
According to the Japan Society for the Study of Obesity, 20% of women in their 20s in Japan are underweight, one of the highest rates among developed countries.
JAPAN / Science & Health
Jun 10, 2025
Female Underweight/Undernutrition Syndrome to be classified disorder
According to one group, 20% of women in their 20s in Japan are underweight.
A University of Osaka study of more than 1,400 fourth-graders has found that children who chew poorly and eat quickly are significantly more likely to be obese.
JAPAN / Science & Health
May 26, 2025
Study links poor chewing to higher obesity risk in children
The University of Osaka study involving over 1,400 fourth-graders is among the first to demonstrate a clear link between eating behavior and obesity risk in children.
Shares of Eli Lilly & Co. surged on the New York Stock Exchange on Thursday after early reports of its experimental weight-loss drug put in a par with market leader Ozempic. The stocks of the drug’s originator, Chugai Pharmaceutical Co., also saw an uptick.
BUSINESS / Companies
Apr 18, 2025
Weight-loss pill orforglipron shines in study, boosting Lilly and Chugai
Eli Lilly’s orforglipron pill, licensed from Chugai Pharmaceutical, could reshape the booming weight-loss drug market, early data shows.
A research team found that brown fat, which encourages the body to burn fat, tended to be more active among those conceived during the colder months, meaning they are less likely to gain weight.
JAPAN / Science & Health
Apr 9, 2025
Japanese team finds people conceived in winter less likely to be overweight
The team analyzed the brown fat of 356 men between the ages of 18 and 29.
An event marking World Obesity Day in Brussels on March 6, 2024. Without a serious change, researchers estimate that 3.8 billion adults will be overweight or obese in 15 years — or around 60% of the global adult population in 2050.
WORLD / Science & Health
Mar 4, 2025
60% of adults will be overweight or obese by 2050, study says
Data from 204 countries paints a grim picture of a major health challenge facing the world.
Excess sugar intake — especially of sucrose, or table sugar — can lead to ailments such as obesity and diabetes.
JAPAN / Science & Health
Feb 17, 2025
Researchers discover bacteria that can limit body’s sugar absorption
Researchers hope the findings will contribute to developing a new treatment method for obesity and diabetes.
A food delivery worker rides through Shenzhen's Futian district in May 2022.
ASIA PACIFIC / Society
Sep 3, 2024
China’s economic malaise seen accelerating obesity rates
Job stress, long work hours and poor diets are growing high-risk factors in cities, while in rural areas, agriculture work is becoming less physically demanding.

Longform

Famima Park Azabudai is a concept store by FamilyMart that combines convenience store staples with branded apparel, merchandise and a landscaped outdoor space.
Convenience stores, toilets and the allure of everyday Japan

SUSTAINABLE JAPAN